CHEST-CA: Study of Chest Pain and Hidden Cardiac Amyloidosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age65+
SponsorRigshospitalet, Denmark
About this trial
The objective of this observational, prospective study is to determine the prevalence of Cardiac Amyloidosis (CA) in males over the age of 65 who experience chest pain but show no signs of coronary artery disease (CAD).
Prior to inclusion, all patients will have undergone a CT coronary angiogram or an Rb-PET scan to rule out the possibility of CAD.
Participants will be subject to several examinations, including blood tests, urine samples, ECG, echocardiography, and bone scintigraphy. An endomyocardial biopsy may be conducted if necessary.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Design model
Single group
Treatments tested in this trial
Screening thourgh examinations including bonescintigraphy
Other interventionClinical examination, blood samples, echo, bone scintigraphy
Treatment groups
300 Participants
are divided into 1 treatment groupGroup A: Interventional groupOther 1 intervention
Trial outcomes
Primary outcomes
1
Prevalence of ATTR-CA in patients experiencing chest pain
Time frame
Up to 4 weeksSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov